AMPH

Amphastar Pharmaceuticals, Inc. is a prominent specialty pharmaceutical company dedicated to the development, manufacturing, and commercialization of both generic and proprietary injectable, inhalation, and intranasal products. Primarily serving the U.S. market while expanding internationally in regions such as China and France, Amphastar leverages its advanced research and development expertise alongside a comprehensive manufacturing infrastructure to target critical therapeutic areas. With a steadfast commitment to innovation and high-quality standards, the company is strategically positioned to harness growth opportunities within the evolving global pharmaceutical market.